Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong · Delayed Price · Currency is HKD 33.06
-0.80 (-2.36%)
Oct 2, 2026, 3:59 PM HKT
HKG:1501 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,982 | 5,252 | 5,095 | 4,891 | 4,830 | 3,818 | |
Market Cap Growth | 23.69% | 3.09% | 4.18% | 1.25% | 26.51% | -43.77% |
Enterprise Value | 6,383 | 5,415 | 4,791 | 4,547 | 4,206 | 2,982 |
Last Close Price | 33.06 | 29.74 | 28.72 | 28.06 | 27.93 | 21.84 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.51 | 22.89 | 26.47 | 29.23 | 32.83 | 21.76 |
Forward PE | - | 23.03 | 18.88 | 20.44 | 20.89 | 23.81 |
PS Ratio | 5.04 | 4.43 | 5.62 | 5.90 | 7.29 | 6.69 |
PB Ratio | 2.13 | 2.26 | 2.68 | 2.65 | 2.75 | 2.16 |
P/TBV Ratio | 3.06 | 3.79 | 2.98 | 2.92 | 2.84 | 2.24 |
P/FCF Ratio | 16.36 | 16.64 | 47.97 | 476.97 | - | - |
P/OCF Ratio | 13.83 | 13.56 | 21.23 | 24.92 | 23.68 | 42.75 |
PEG Ratio | - | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.61 | 4.57 | 5.29 | 5.48 | 6.35 | 5.23 |
EV/EBITDA Ratio | 12.73 | 13.78 | 15.70 | 20.16 | 23.26 | 14.39 |
EV/EBIT Ratio | 17.41 | 18.84 | 21.24 | 25.48 | 28.77 | 16.79 |
EV/FCF Ratio | 14.95 | 17.16 | 45.11 | 443.50 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.25 | 0.34 | 0.14 | 0.06 | 0.03 | 0.01 |
Debt / EBITDA Ratio | 1.65 | 1.98 | 0.84 | 0.45 | 0.29 | 0.08 |
Debt / FCF Ratio | 1.94 | 2.52 | 2.44 | 10.18 | - | - |
Net Debt / Equity Ratio | -0.21 | 0.03 | -0.17 | -0.20 | -0.31 | -0.44 |
Net Debt / EBITDA Ratio | -1.43 | 0.19 | -1.07 | -1.66 | -3.00 | -3.71 |
Net Debt / FCF Ratio | -1.64 | 0.23 | -3.09 | -36.49 | 7.64 | 3.06 |
Asset Turnover | 0.36 | 0.40 | 0.40 | 0.39 | 0.34 | 0.31 |
Inventory Turnover | 2.34 | 2.40 | 2.16 | 2.22 | 2.05 | 2.56 |
Quick Ratio | 1.51 | 0.94 | 1.54 | 1.77 | 2.51 | 4.70 |
Current Ratio | 1.82 | 1.26 | 2.05 | 2.29 | 3.35 | 5.60 |
Return on Equity (ROE) | 10.66% | 12.01% | 10.97% | 9.48% | 8.95% | 10.16% |
Return on Assets (ROA) | 5.88% | 5.99% | 6.18% | 5.25% | 4.69% | 5.94% |
Return on Invested Capital (ROIC) | 12.88% | 12.81% | 13.41% | 11.74% | 12.71% | 21.77% |
Return on Capital Employed (ROCE) | 10.80% | 11.10% | 11.60% | 9.50% | 8.10% | 9.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.61% | 4.63% | 4.01% | 3.52% | 3.08% | 4.60% |
FCF Yield | 6.11% | 6.01% | 2.08% | 0.21% | -1.47% | -6.59% |
Dividend Yield | 0.79% | 0.86% | - | 1.06% | 0.97% | 1.46% |
Payout Ratio | 19.90% | - | 24.55% | 25.77% | 33.16% | 33.09% |
Buyback Yield / Dilution | -9.77% | -0.92% | 0.11% | -1.10% | -1.32% | -0.48% |
Total Shareholder Return | -8.98% | -0.06% | 0.11% | -0.04% | -0.35% | 0.98% |